-
Uncategorized1 month agoEpic’s alleged anticompetitive practices under scrutiny from federal, state investigators
The Federal Trade Commission is examining Epic Systems Corp., the nation’s largest vendor of electronic health records, for potential violations of antitrust law as part of...
-
Uncategorized1 month agoOpinion: AAP president: How pediatricians are navigating federal leaders’ fear-mongering on vaccines
Every parent experiences a unique mix of emotions when caring for a newborn baby. You’re filled with an overwhelming sense of pride, love, and awe for...
-
Uncategorized1 month agoBristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene
The clearance of Zenbexus is the first for a group of protein-degrading “CELMoD” medicines that could help Bristol Myers rejuvenate a key drug franchise.
-
Uncategorized1 month agoBMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C. auris
Bristol Myers Squibb has selected Houston as the site for a new $2.3 billion multi-modal manufacturing campus designed to support drug product and finished goods manufacturing...
-
Uncategorized1 month ago
Capricor soars on potential FDA review extension, filing amendments
Capricor soars on potential FDA review extension, filing amendments
-
Uncategorized1 month agoSFA Spectroscopy Chases Away Cloudy Samples
Brendan Darby, PhDCo-founder and CEOMarama Labs Characterizing the RNA and ligands in nanoparticle-based therapeutics has, historically, been a cumbersome process. The lipid nanoparticles (LNPs) that encase...
-
Uncategorized1 month agoSTAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more
And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to...
-
Uncategorized1 month agoSTAT+: Drug-testing lab that has sparked controversy sues group that develops drug standards over criticism
A laboratory that tussled with regulators over impurities found in some widely used medicines has accused the group U.S. Pharmacopeia of making false and misleading remarks...
-
Uncategorized1 month agoThis week in Drug Discovery (10-14 August 2026)
News round-up for 10-14 August by Diana Turner, Content Team at DDW. This week’s news round-up highlights new discoveries in cancer research, including the first trial...
-
Uncategorized1 month ago
Skye and Redx form new entity with $125M to advance fibrosis assets
Skye Bioscience has entered into an agreement to combine with privately held fibrotic disease biotech Redx Pharma in a deal that will net $125 million in...
FDA clears first generic radioligand drug; Sionna turns to layoffs
WCLC ‘26: A new ‘ADC era,’ China questions and AstraZeneca’s spotlight
Ensuring safety and accountability in China’s biomedical translation system
Scientists turn pig semen extract into eye drops that kill cancer in mice
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
